首页> 美国卫生研究院文献>other >Emergency Physician Patterns Related to Anticoagulation of Patients with Recent-Onset Atrial Fibrillation and Flutter
【2h】

Emergency Physician Patterns Related to Anticoagulation of Patients with Recent-Onset Atrial Fibrillation and Flutter

机译:与近期发作的房颤和扑动患者抗凝相关的急诊医师模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Guidelines strongly recommend long-term anticoagulation with warfarin for patients with newly recognized AF who have high embolic risk by virtue of a CHADS2 (Congestive Heart Failure, Hypertension, Age >65, Diabetes, History of Stroke) score ≥ 2. The goal of this study was to determine patterns of emergency department-initiated anticoagulation among eligible patients discharged from Canadian centers with an episode of recent-onset atrial fibrillation and flutter (RAFF) and determine if decision-making is driven by the CHADS2 score or other factors. This was accomplished by examining health records using uniform case identification and data abstraction as well as centralized quality control; it was conducted in 8 Canadian university emergency departments over a 12-month period. Eligible patients for this analysis demonstrated RAFF requiring emergency management, were not already taking warfarin and were not admitted to hospital. Univariate analyses were conducted using T-test or Chi-square to select factors associated with anticoagulation initiation at a significance level of p < 0.15 and multiple logistic regression was employed to evaluate independent predictors after adjustment for confounders. Among 633 eligible patients, only 21 out of 120 patients (18%) with a CHADS2 score ≥ 2 received anticoagulation and among 70 patients who were given anticoagulation only 21 (30%) had a CHADS2 score ≥ 2. Independent predictors of anticoagulation included age by 10-year strata: (OR = 1.7; 95% CI 1.3 – 2.1), heparin use in the anticoagulation (OR = 9.6; 95% CI 4.9 – 18.9), a new prescription for metoprolol (OR = 9.6; 95% CI 4.9 – 18.9) and being referred to cardiology for follow-up (OR = 5.6; 95% CI 2.6 – 12.0). CHADS2 ≥ 2 doubled the likelihood of being prescribed anticoagulation (OR= 2.0; 95% CI 1.5 – 3.5) but was not an independent predictor. It was thus determined that patients discharged from the emergency department in this study were not prescribed anticoagulation in keeping with current recommendations. This practice gap merits further investigation and may benefit from educational efforts or enhanced support for anticoagulation use from the emergency department.
机译:指南强烈建议对于因CHADS2(充血性心力衰竭,高血压,年龄> 65岁,糖尿病,中风病史)评分≥2而具有较高栓塞风险的新近认可的AF患者,应长期应用华法林抗凝治疗。该研究旨在确定从加拿大中心出院的,近期发作的房颤和扑动(RAFF)发作的合格患者中急诊科启动的抗凝模式,并确定决策是否由CHADS2评分或其他因素驱动。这是通过使用统一的病例识别和数据抽象以及集中质量控制检查健康记录来完成的;它在12个月内在加拿大的8个大学急诊科进行。符合此分析条件的患者表明,RAFF需要紧急治疗,尚未服用华法林且未入院。使用T检验或卡方检验进行单变量分析,以选择p <0.15的显着性水平与抗凝起始相关的因素,并在校正混杂因素后采用多元逻辑回归评估独立的预测因素。在633例合格患者中,CHADS2评分≥2的120例患者中只有21例(18%)接受了抗凝治疗,而接受抗凝治疗的70例患者中只有CHADS2评分≥2的患者中有21例(30%)接受了抗凝治疗。到10年分层:(OR = 1.7; 95%CI 1.3 – 2.1),抗凝使用肝素(OR = 9.6; 95%CI 4.9 – 18.9),美托洛尔的新处方(OR = 9.6; 95%CI 4.9 – 18.9),并转诊至心脏病科进行随访(OR = 5.6; 95%CI 2.6 – 12.0)。 CHADS2≥2被处方抗凝治疗的可能性翻了一番(OR = 2.0; 95%CI 1.5 – 3.5),但不是独立的预测因素。因此可以确定,在本研究中,从急诊科出院的患者未按照现行建议进行抗凝治疗。这种做法的差距值得进一步调查,并且可能会受益于急诊科的教育努力或对抗凝治疗的更多支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号